Clinical Trial Update: Hydroxychloroquine Versus Placebo in Primary Sjögren's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hydroxychloroquine versus placebo for Primary Sjögren's Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Primary Sjögren's Syndrome | Phase 3 | Status: COMPLETED